Keywords: Sanofi, Genzyme, Aubagio, Multiple sclerosis, USA, FDA

FDA thumbs up for Sanofi's MS drug Aubagio

Article | 13 September 2012

Print This

As has been largely expected, the US Food and Drug Administration yesterday approved marketing of French drug major Sanofi (Euronext ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in